Empagliflozin 25 mg

About Empagliflozin 25 mg

EMPATECH 25 contains Empagliflozin 25 mg, a highly effective oral antidiabetic medication from the SGLT2 inhibitor class. Designed for adults with type 2 diabetes mellitus, EMPATECH 25 helps control blood sugar levels by promoting glucose excretion through urine, independent of insulin pathways.

This makes it an excellent option for patients seeking improved glycemic control, weight management, and cardiovascular support.

Key Ingredient:

• Empagliflozin 25 mg A potent Sodium-Glucose Co-Transporter-2 (SGLT2) inhibitor that reduces blood glucose levels by increasing urinary glucose excretion.

Key Benefits:

• Effectively lowers blood sugar levels in patients with type 2 diabetes

• Supports weight loss and reduction in blood pressure

• Cardiovascular benefits reduces the risk of heart failure-related hospitalizations

• Helps in preserving kidney function in diabetic nephropathy

• Can be used as monotherapy or in combination with other antidiabetic drugs

How Does It Work?

Empagliflozin inhibits the SGLT2 protein in the kidneys, preventing glucose reabsorption into the bloodstream. This promotes the elimination of excess glucose through urine, leading to improved glycemic control and additional metabolic benefits such as weight reduction and blood pressure improvement.

Directions for Use:

• Take one tablet of EMPATECH 25 daily, with or without food

• Follow the dosage as prescribed by your healthcare professional

• Maintain proper hydration during treatment

• Regularly monitor your blood sugar levels for optimal results

Precautions & Side Effects:

• Not recommended for patients with type 1 diabetes or diabetic ketoacidosis

• Possible side effects: urinary tract infections, genital infections, increased urination, and dehydration

• Inform your doctor if you experience symptoms like dizziness, low blood pressure, or signs of urinary tract issues

• Use with caution in patients with impaired renal function

EMPATECH 25 Empowering diabetic care with innovative SGLT2 inhibition for holistic management of blood sugar, heart, and kidney health.